The role of device therapy in heart failure with reduced ejection fraction(HFrEF):a narrative review
FU Bing-qi
WANG Qi
TAN Tong
WEI Xue-biao
YU Dan-qing
Division of Cardiology,Guangdong Cardiovascular Institute,Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention,Guangdong Provincial People's Hos-pital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China
摘要：Heart failure has gained increasing notice due to its high prevalence and mortality rate.The manage-ment for heart failure has been emphasized on the role of device therapy.Implantable cardioverter defibrillator(ICD)and cardiac resynchronization therapy(CRT)were given strong recommendation for heart failure with re-duced ejection fraction(HFrEF),considering their effectiveness on preventing sudden cardiac death(SCD),im-proving cardiac function and benefiting survival.In this review,we explained the underlying mechanisms of dis-ease initiation and progression in HFrEF,in order to build the connection between the pathological basis of HFrEF and the rationality of ICD and CRT on terminating ventricular arrhythmia,improving cardiac function,decreasing the rate of adverse clinical outcomes and benefiting survival.In addition,we discussed the high-quality researches with significant values on the discovery of device therapy clinical benefits,and compared the class Ⅰ recommenda-tions for device therapy in HFrEF,suggested by American Heart Association and European Society of Cardiology.
机标关键词：fractiondevicereviewheartrolewithejectionfailure
论文发表日期：2022-09-30
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：14( 215-228 )
英文信息